Skip to main content
Emily Podany, MD, Internal Medicine, Saint Louis, MO

EmilyLaurenPodanyMD

Internal Medicine Saint Louis, MO

Hematology/Oncology

Hematology/Oncology Fellow

Dr. Podany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Podany's full profile

Already have an account?

  • Office

    1 Barnes Jewish Hospital Plz
    Saint Louis, MO 63110
    Phone+1 314-362-4957

Summary

  • Emily Podany, MD, is an internal medicine specialist based in Saint Louis, MO. Her subspeciality is in Hematology/Oncology, with a focus on breast cancer treatment and health equity. She completed her M.D., residency, and chief residency in Internal Medicine at Baylor College of Medicine and is currently undertaking a fellowship in Hematology and Medical Oncology at Washington University/B-JH/SLCH Consortium.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2022 - 2025
  • Baylor College of Medicine
    Baylor College of MedicineChief Residency, Internal Medicine, 2021 - 2022
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2018 - 2021
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2018, M.D.

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2022 - 2025
  • TX State Medical License
    TX State Medical License 2021 - 2023
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • Black Women with Breast Cancer Face Clinical Inequities
    Black Women with Breast Cancer Face Clinical InequitiesJuly 26th, 2024
  • Guardant Health and Washington University to Present Study at 2024 ASCO Meeting Highlighting Utility of ctDNA to Address Racial Inequities in the Use of Targeted Therapies and Enrollment in Clinical Trials
    Guardant Health and Washington University to Present Study at 2024 ASCO Meeting Highlighting Utility of ctDNA to Address Racial Inequities in the Use of Targeted Therapies and Enrollment in Clinical TrialsJune 4th, 2024